185 related articles for article (PubMed ID: 18473416)
1. Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease.
Huang XD; Fan Y; Zhang H; Wang P; Yuan JP; Li MJ; Zhan XY
World J Gastroenterol; 2008 May; 14(18):2888-93. PubMed ID: 18473416
[TBL] [Abstract][Full Text] [Related]
2. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population.
Ogawa T; Hirose H; Yamamoto Y; Nishikai K; Miyashita K; Nakamura H; Saito I; Saruta T
Metabolism; 2004 Jul; 53(7):879-85. PubMed ID: 15254881
[TBL] [Abstract][Full Text] [Related]
3. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
[TBL] [Abstract][Full Text] [Related]
4. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
5. Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease.
Aller R; De Luis DA; Izaola O; González Sagrado M; Conde R; Pacheco D; Velasco MC; Ovalle HF
Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):335-41. PubMed ID: 22530350
[TBL] [Abstract][Full Text] [Related]
6. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome.
Sandhofer A; Laimer M; Ebenbichler CF; Kaser S; Paulweber B; Patsch JR
Obes Res; 2003 Jun; 11(6):760-8. PubMed ID: 12805397
[TBL] [Abstract][Full Text] [Related]
7. Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease.
Medici V; Ali MR; Seo S; Aoki CA; Rossaro L; Kim K; Fuller WD; Vidovszky TJ; Smith W; Jiang JX; Maganti K; Havel PJ; Kamboj A; Ramsamooj R; Török NJ
Obesity (Silver Spring); 2010 Dec; 18(12):2268-73. PubMed ID: 20448542
[TBL] [Abstract][Full Text] [Related]
8. Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects.
Hossain IA; Akter S; Rahman MK; Ali L
PLoS One; 2015; 10(11):e0142165. PubMed ID: 26569494
[TBL] [Abstract][Full Text] [Related]
9. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
10. Leptin in nonalcoholic fatty liver disease.
Canbakan B; Tahan V; Balci H; Hatemi I; Erer B; Ozbay G; Sut N; Hacibekiroglu M; Imeryuz N; Senturk H
Ann Hepatol; 2008; 7(3):249-54. PubMed ID: 18753993
[TBL] [Abstract][Full Text] [Related]
11. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver.
Serin E; Ozer B; Gümürdülü Y; Kayaselçuk F; Kul K; Boyacioğlu S
J Gastroenterol; 2003; 38(5):471-6. PubMed ID: 12768390
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
14. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
Hu ZW; Guo JW; Deng XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
[TBL] [Abstract][Full Text] [Related]
15. Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI: high normal BMI is the threshold for serum leptin increase in humans.
Owecki M; Nikisch E; Miczke A; Pupek-Musialik D; Sowiński J
Horm Metab Res; 2010 Jul; 42(8):585-9. PubMed ID: 20455195
[TBL] [Abstract][Full Text] [Related]
16. Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor.
Swellam M; Hamdy N
IUBMB Life; 2012 Feb; 64(2):180-6. PubMed ID: 22215535
[TBL] [Abstract][Full Text] [Related]
17. Leptin, leptin soluble receptor and coronary atherosclerosis.
Hoefle G; Saely CH; Risch L; Rein P; Koch L; Schmid F; Aczél S; Marte T; Langer P; Drexel H
Eur J Clin Invest; 2007 Aug; 37(8):629-36. PubMed ID: 17635573
[TBL] [Abstract][Full Text] [Related]
18. Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children.
Reinehr T; Kratzsch J; Kiess W; Andler W
Int J Obes (Lond); 2005 Oct; 29(10):1230-5. PubMed ID: 15997245
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in patients with nonalcoholic steatohepatitis.
Uygun A; Kadayifci A; Yesilova Z; Erdil A; Yaman H; Saka M; Deveci MS; Bagci S; Gulsen M; Karaeren N; Dagalp K
Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
